Crosswinds Holdings Inc Stock Toronto S.E.
Equities
CA2276961018
Biotechnology & Medical Research
Sales 2021 | - | Sales 2022 | - | Capitalization | 27.36M 37.37M |
---|---|---|---|---|---|
Net income 2021 | -4M -5.46M | Net income 2022 | -2M -2.73M | EV / Sales 2021 | - |
Net cash position 2021 | 2.23 3.04 | Net cash position 2022 | 0.02 0.02 | EV / Sales 2022 | - |
P/E ratio 2021 |
-17.8
x | P/E ratio 2022 |
-9.17
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 60.21% |
1st Jan change | Capi. | |
---|---|---|
+1.12% | 43.84B | |
+6.77% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+6.01% | 25.53B | |
-24.92% | 18.18B | |
-3.63% | 12.29B | |
+27.16% | 12.29B | |
+7.30% | 11.15B |